These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Age of first faint in patients with vasovagal syncope. Sheldon RS; Sheldon AG; Connolly SJ; Morillo CA; Klingenheben T; Krahn AD; Koshman ML; Ritchie D; J Cardiovasc Electrophysiol; 2006 Jan; 17(1):49-54. PubMed ID: 16426400 [TBL] [Abstract][Full Text] [Related]
3. Recent history of vasovagal syncope in a young, referral-based population is a stronger predictor of recurrent syncope than lifetime syncope burden. Sumner GL; Rose MS; Koshman ML; Ritchie D; Sheldon RS; J Cardiovasc Electrophysiol; 2010 Dec; 21(12):1375-80. PubMed ID: 20662990 [TBL] [Abstract][Full Text] [Related]
4. Prevention of Syncope Trial (POST): a randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope. Sheldon R; Connolly S; Rose S; Klingenheben T; Krahn A; Morillo C; Talajic M; Ku T; Fouad-Tarazi F; Ritchie D; Koshman ML; Circulation; 2006 Mar; 113(9):1164-70. PubMed ID: 16505178 [TBL] [Abstract][Full Text] [Related]
5. Prevalence and correlates of syncope-related traumatic injuries in tilt-induced vasovagal syncope. Ammirati F; Colivicchi F; Velardi A; Santini M Ital Heart J; 2001 Jan; 2(1):38-41. PubMed ID: 11214700 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of tilt training in patients with vasovagal syncope. Gajek J; Zyśko D; Mazurek W Kardiol Pol; 2006 Jun; 64(6):602-8; discussion 609-10. PubMed ID: 16810579 [TBL] [Abstract][Full Text] [Related]
8. Self-reported symptom burden; outcome in 418 patients from the Newcastle Vasovagal (Neurocardiogenic) cohort. Ross R; Parry S; Norton M; Newton JL QJM; 2008 Feb; 101(2):127-35. PubMed ID: 18184666 [TBL] [Abstract][Full Text] [Related]
9. Timing of first recurrence of syncope predicts syncopal frequency after a positive tilt table test result. Malik P; Koshman ML; Sheldon R J Am Coll Cardiol; 1997 May; 29(6):1284-9. PubMed ID: 9137225 [TBL] [Abstract][Full Text] [Related]
10. Effectiveness of midodrine treatment in patients with recurrent vasovagal syncope not responding to non-pharmacological treatment (STAND-trial). Romme JJ; van Dijk N; Go-Schön IK; Reitsma JB; Wieling W Europace; 2011 Nov; 13(11):1639-47. PubMed ID: 21752826 [TBL] [Abstract][Full Text] [Related]
11. Vasovagal syncope in medical students and their first-degree relatives. Serletis A; Rose S; Sheldon AG; Sheldon RS Eur Heart J; 2006 Aug; 27(16):1965-70. PubMed ID: 16837484 [TBL] [Abstract][Full Text] [Related]
12. Norepinephrine transport inhibition for treatment of vasovagal syncope. Sheldon RS; Ritchie D; McRae M; Raj S J Cardiovasc Electrophysiol; 2013 Jul; 24(7):799-803. PubMed ID: 23444896 [TBL] [Abstract][Full Text] [Related]
13. Effect of metoprolol on quality of life in the Prevention of Syncope Trial. Sheldon RS; Amuah JE; Connolly SJ; Rose S; Morillo CA; Talajic M; Kus T; Fouad-Tarazi F; Klingenheben T; Krahn AD; Koshman ML; Ritchie D; J Cardiovasc Electrophysiol; 2009 Oct; 20(10):1083-8. PubMed ID: 19563364 [TBL] [Abstract][Full Text] [Related]
14. Can prodromal symptoms predict recurrence of vasovagal syncope? Fazelifar AF; Basiri HA; Tolooie A; Haghjoo M; Barakpour H; Emkanjoo Z; Abkenar HB; Zeighami M; Asgari F; Sadr-Ameli MA Cardiol J; 2008; 15(5):446-50. PubMed ID: 18810720 [TBL] [Abstract][Full Text] [Related]
15. The role of tilt training in preventing recurrent syncope in patients with vasovagal syncope: a prospective and randomized study. Duygu H; Zoghi M; Turk U; Akyuz S; Ozerkan F; Akilli A; Erturk U; Onder R; Akin M Pacing Clin Electrophysiol; 2008 May; 31(5):592-6. PubMed ID: 18439174 [TBL] [Abstract][Full Text] [Related]
16. High Remission Rates in Vasovagal Syncope: Systematic Review and Meta-Analysis of Observational and Randomized Studies. Pournazari P; Sahota I; Sheldon R JACC Clin Electrophysiol; 2017 Apr; 3(4):384-392. PubMed ID: 29759452 [TBL] [Abstract][Full Text] [Related]
17. Distinguishing cardiac syncope from vasovagal syncope in a referral population. Tretter JT; Kavey RE J Pediatr; 2013 Dec; 163(6):1618-1623.e1. PubMed ID: 23992679 [TBL] [Abstract][Full Text] [Related]
18. Predictors of response to the head-up tilt test in patients with unexplained syncope or presyncope. Kazemi B; Haghjoo M; Arya A; Sadr-Ameli MA Pacing Clin Electrophysiol; 2006 Aug; 29(8):846-51. PubMed ID: 16923000 [TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics of patients with vasovagal reactions presenting as unexplained syncope. Graham LA; Kenny RA Europace; 2001 Apr; 3(2):141-6. PubMed ID: 11333052 [TBL] [Abstract][Full Text] [Related]
20. Prevalence, timing, and haemodynamic correlates of prodromes in patients with vasovagal syncope induced by head-up tilt test. Guida P; Iacoviello M; Forleo C; Ferrara A; Sorrentino S; Balducci C; Sarlo M; Favale S Europace; 2009 Sep; 11(9):1221-6. PubMed ID: 19570809 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]